YDES Stock Summary and Trading Ideas (YD Bio Limited - | NASDAQ:YDES)

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

YD Bio Limited - trades on the NASDAQ stock market under the symbol YDES.

As of November 12, 2026, YDES stock price declined to $5.20 with 78,192 million shares trading.

YDES has a beta of 0.29, meaning it tends to be less sensitive to market movements. YDES has a correlation of 0.00 to the broad based SPY ETF.

YDES has a market cap of $367.97 million. This is considered a Small Cap stock.

YDES has underperformed the market in the last year with a price return of -41.2% while the SPY ETF gained +12.0%. However, in the short term, YDES had mixed performance relative to the market. It has outperformed in the last 3 months, returning +90.3% vs -1.5% return in SPY. But in the last 2 weeks, YDES shares have been beat by the market, returning -17.3% compared to an SPY return of -2.0%.

YDES support price is $5.49 and resistance is $6.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that YDES shares will trade within this expected range on the day.